Opthea Ltd: Voluntary suspension

Mar 18 18:36 ET

Opthea Ltd: Trading Halt

Mar 16 17:41 ET

Opthea Ltd: Opthea Announces Phase 2b Wet AMD Publication

Mar 2 16:22 ET

Opthea Ltd: Opthea Completes Drug Product PPQ Campaign

Feb 25 16:06 ET

Opthea Ltd: Opthea Completes COAST Final Week 52 Patient Visit

Feb 17 16:18 ET

Opthea Ltd: Opthea to Present at Oppenheimer Healthcare Conference

Feb 6 16:31 ET

Opthea Ltd: Opthea Wet AMD Data Featured at Macula Society Meeting

Feb 5 17:14 ET

Opthea Ltd: Opthea to Host Investor Days in New York and Australia

Jan 7 17:18 ET

Opthea Ltd: Opthea Announces Publication in Diabetic Macular Edema

Jan 6 16:22 ET

Opthea Ltd: Opthea to Present at 43rd J.P. Morgan Healthcare Conference

Dec 18, 2024 16:38 ET

Opthea Ltd: Opthea's Wet AMD Program to be Featured at FLORetina 2024

Nov 25, 2024 16:23 ET

Opthea Ltd: Opthea Participate in Citi 2024 Global Healthcare Conference

Nov 24, 2024 17:49 ET

Opthea Ltd: Opthea's Wet AMD Program Featured at Ophthalmology Events

Nov 11, 2024 16:45 ET

Opthea Ltd: Update Opthea Participates in November Investor Conferences

Nov 3, 2024 19:33 ET

Opthea Ltd: Opthea to Participate in November Investor Conferences

Nov 3, 2024 16:25 ET

Opthea Ltd: Opthea Wet AMD Program to be Presented at Innovate Retina

Oct 9, 2024 17:42 ET

Opthea Ltd: Opthea Appoints Chief Medical and Chief Financial Officer

Oct 7, 2024 17:51 ET

Opthea Ltd: Opthea to participate in UBS Virtual Ophthalmology Day 2024

Sep 30, 2024 18:10 ET

Opthea Ltd: Opthea Joins the S&P/ASX 300 Index

Sep 22, 2024 18:31 ET

Opthea Ltd: Opthea Announces Completion of Drug Substance Campaign

Sep 18, 2024 18:19 ET